Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.97M Buy
197,187
+12,410
+7% +$761K 0.06% 293
2026
Q1
$12.1M Buy
+184,777
New +$13.5M 0.1% 195
2025
Q4
Sell
-62,645
Closed -$5.14M 1653
2025
Q3
$5.14M Buy
+62,645
New +$5.43M 0.05% 405
2025
Q2
Sell
-177,059
Closed -$16.2M 1581
2025
Q1
$16.2M Buy
+177,059
New +$15.5M 0.16% 124
2024
Q3
Sell
-3,457
Closed -$273K 1724
2024
Q2
$273K Buy
+3,457
New +$284K ﹤0.01% 1351
2024
Q1
Sell
-4,517
Closed -$397K 1600
2023
Q4
$397K Buy
+4,517
New +$376K ﹤0.01% 1099
2022
Q4
Sell
-48,625
Closed -$3.86M 1737
2022
Q3
$3.86M Sell
48,625
-17,584
-27% -$1.49M 0.05% 499
2022
Q2
$5.52M Sell
66,209
-6,832
-9% -$563K 0.07% 373
2022
Q1
$6M Buy
73,041
+5,589
+8% +$438K 0.08% 325
2021
Q4
$5.05M Buy
67,452
+55,150
+448% +$4.14M 0.05% 431
2021
Q3
$931K Sell
12,302
-9,461
-43% -$732K 0.01% 1060
2021
Q2
$1.68M Sell
21,763
-13,810
-39% -$1.07M 0.02% 759
2021
Q1
$2.5M Buy
+35,573
New +$2.69M 0.04% 486
2020
Q4
Sell
-3,747
Closed -$215K 2044
2020
Q3
$215K Buy
+3,747
New +$224K ﹤0.01% 1440
2019
Q3
Sell
-8,740
Closed -$543K 1403
2019
Q2
$543K Buy
8,740
+1,997
+30% +$115K 0.02% 427
2019
Q1
$365K Buy
+6,743
New +$379K 0.03% 412

Other funds holding DOX

Michael Gelband's DOX Position: Q2 2026 in Review

Michael Gelband increased its Amdocs (DOX) stake by 6.7% in Q2 2026, buying an estimated $761K and bringing the position to 197,187 shares worth $9.97M. The position accounts for 0.06% of the portfolio, ranked #293.

Michael Gelband first reported a position in DOX in Q1 2019 and has held it in 16 quarters since. The position peaked at $16.2M in Q1 2025. 446 funds tracked by Wall St. Rank hold DOX as of Q2 2026.

  • Michael Gelband held 197,187 shares of Amdocs worth $9.97M as of Q2 2026.
  • Michael Gelband bought 12,410 Amdocs shares in Q2 2026, an estimated $761K.
  • Amdocs made up 0.06% of Michael Gelband's portfolio in Q2 2026, its #293 holding.
  • Michael Gelband first reported a position in Amdocs in Q1 2019 and has held it in 16 quarters since.
  • Michael Gelband's Amdocs position peaked at $16.2M in Q1 2025.
  • 446 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.